Drug Trial Radar · NCT04968613
Dopaminergic Mechanism of Memory Impairment in Parkinson's Disease
Last checked: Nov 20, 2026Latest source record: Jul 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Jan 1, 2018
Primary completion
Dec 31, 2021
Study completion Dec 31, 2021
Sponsor
- Lead sponsor
- Peking University Third HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Chinese Academy of Sciences
- First posted
- Jul 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The cognitive impairment of Parkinson's disease is non amnestic, which is characterized by working memory impairment and executive dysfunction. The current drug therapy (such as levodopa, dopamine receptor agonists) and surgical treatment (such as deep brain electrical stimulation, thalamic lesion) not only can not effectively alleviate cognitive impairment, but also may aggravate cognitive and speech behavior abnormalities. This project will explore how dopamine regulates temporal working memory in human research by combining drug intervention, neuroimaging and cognitive tasks.
Conditions
- Parkinson Disease
- Memory Impairment
Interventions
Madopar monotherapyDrug
In addition to basic treatment, the patient also received Madopar treatment
senfrol monotherapyDrug
In addition to the basic treatment, the patient also received the rofosson treatment
placebo monotherapyDrug
In addition to basic treatment, the patient also received selegiline treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of cognition functionTime frame: 12 months after the trail
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University Third Hospital
Beijing, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.